Inhibition of NF-κB induces apoptosis of KSHV-infected primary effusion lymphoma cells

Blood

Volumn 96, Issue 7, 2000, Pages 2537-2542

  Keller, S A ^a   Schattner, E J ^a   Cesarman, E ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; CELL PROTEIN; DNA; ENZYME INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR PROTEIN; INTERLEUKIN 6; PROTEIN P50; SYNAPTOTAGMIN; UNCLASSIFIED DRUG; ACETYLSALICYLIC ACID; MESSENGER RNA; SALICYLATE SODIUM;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; ELECTROPHORETIC MOBILITY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HUMAN T CELL LEUKEMIA VIRUS 1; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFORMATION; LYMPHOMA CELL; PRIORITY JOURNAL; PROTEIN DNA BINDING; VIRUS CARCINOGENESIS; BIOSYNTHESIS; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; KAPOSI SARCOMA; LYMPHOMA; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY;

APOPTOSIS; ASPIRIN; CELL SURVIVAL; HERPESVIRUS 8, HUMAN; HUMANS; INTERLEUKIN-6; LYMPHOMA; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SARCOMA, KAPOSI; SODIUM SALICYLATE; TUMOR CELLS, CULTURED;

EID: 0034287445     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.7.2537     Document Type: Article

References (45)

1. Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus
2. Diagnosis of malignant lymphoma in effusions from patients with AiDS by gene rearrangement
3. Primary effusion lymphoma: A distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpesvirus
4. Association of Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138/syndecan-1 antigen
5. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body cavity-based lymphomas
6. Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells
7. Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma
8. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells
9. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus
10. Human herpesvirus type 8 DNA sequences in cell-free plasma and mononuclear cells of Kaposi's sarcoma patients
11. gamma-Interferon production in peripheral blood mononuclear ceils and tumor infiltrating lymphocytes from Kaposi's sarcoma patients: Correlation with the presence of human herpesvirus-8 in peripheral blood mononuclear cells and lesional macrophages
12. Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma
13. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells
14. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain to mediate B lymphocyte growth transformation and activate NF-κB
15. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients
16. Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein
17. Cellular transcription factors and regulation of IL-2 receptor gene expression by HTLV-I tax gene product
18. HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kappa B-like factor
19. The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation
20. An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation
21. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: Role in NF-kappa B activation
22. Human T-cell leukemia virus type 1 Tax induction of NF-kappaB involves activation of the IkappaB kinase alpha (IKKalpha) and IKKbeta cellular kinases
23. Molecular mechanism of tumorigenesis in mice transgenic for the human T cell leukemia virus Tax gene
24. Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells
25. The regulation and roles of Rel/NF-κB transcription factors during lymphocyte activation
26. NF-κB and REL proteins: Evolutionarily conserved mediators of immune responses
27. B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells
28. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta
29. Inhibition of NF-kappa B by sodium salicylate and aspirin
30. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B
31. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence
32. Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo
33. Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus human herpes-virus-8
34. Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line
35. K1 associated nuclear factor-kappa B-dependent promoter activity: A role in Kaposi's sarcoma inflammation?
36. Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins
37. Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus
38. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator
39. The NF-kappa B activation pathway: Its regulation and role in inflammation and cell survival
40. NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/Al is required for CD40 survival signaling in B lymphocytes
41. Rel/NF-kappa B and I kappa B factors in oncogenesis
42. Production and effects of interleukin-6 and other cytokines in patients with non-Hodgkin's lymphoma
43. Cellular and molecular bases of B-cell clonal expansions
44. Tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) in B-lymphocyte function
45. Constitutive cytokine production by primary effusion (body cavity-based) lymphoma-derived cell lines